PDE4A and rheumatoid arthritis: Another PDE4 inhibitor, Ibudilast, reduced the expression and/or secretion of TNF and IL-12/IL-23p40 in activated human leukocytes and RA synovial fibroblasts and further inhibited TH17 cell responses in vivo (Clanchy and Williams, 2019[37]).